Table 2 Characteristics of patients according to the study groups
Variables | Intervention group (n = 1153) | Control group (n = 886) |
|---|---|---|
Age (years) | ||
 Median | 5.0 (IQR 3.0–9.0) | 5.0 (IQR 2.0–8.0) |
 0–4 years | 484 (42.6%) | 431 (49.4%) |
 5–9 years | 383 (33.7%) | 279 (32.0%) |
 10–14 years | 186 (16.4%) | 120 (13.8%) |
 15–17 years | 82 (7.2%) | 42 (4.8%) |
Sex | ||
 Boys | 591 (51.6%) | 440 (50.0%) |
 Girls | 555 (48.4%) | 440 (50.0%) |
Duration of illness (days) | ||
 Median | 3.0 (IQR 2.0–4.0) | 3.0 (IQR 2.0–4.0) |
Chronic disease | ||
 Yes | 75 (6.5%) | 102 (11.5%) |
 No | 1078 (93.5%) | 784 (88.5%) |
 Full vaccination | 1046 (92.7%) | 820 (95.0%) |
 Partial vaccination | 69 (6.1%) | 40 (4.6%) |
 No vaccination | 13 (1.2%) | 3 (0.3%) |
Diagnoses | ||
 Upper respiratory infection | 922 (80.0%) | 675 (76.2%) |
 Lower respiratory infection | 204 (17.7%) | 180 (20.3%) |
 Gastrointestinal infection | 17 (1.5%) | 19 (2.1%) |
 Urinary tract infection | 8 (0.7%) | 10 (1.1%) |
 Skin and soft tissue infection | 2 (0.2%) | 1 (0.1%) |
 Bone and joint infection | 0 | 1 (0.1%) |
 Ambulatory patients | 1136 (98.5%) | 879 (99.2%) |
 Referred to hospital | 17 (1.5%) | 7 (0.8%) |